Abstract
Introduction
Poor nutrition during pregnancy has adverse consequences for the mother and child in both the short and the longer term. Ideally, women should enter pregnancy in a well-nourished state, but supplementation during pregnancy continues to be an important approach to addressing poor maternal nutrition. The World Health Organization (WHO) recommends universal distribution of iron-folic acid supplements to pregnant women in developing countries to prevent and treat iron-deficiency anemia. Many women suffer from multiple micronutrient deficiencies, not just iron deficiency [1] . In recognition of the potential importance to policy of widening the scope of current practice around supplementation, UNICEF, WHO, and the United Nations University (UNU) agreed on the formulation of a multiple micronutrient supplement for use in efficacy and effectiveness trials designed to assess the benefits and costs of replacing the iron-folic acid supplement [2] . The multiple micronutrient formulation is referred to as UNIMMAP (United Nations International Multiple Micronutrient Preparation); the composition of the supplement is given in table 1. A meeting was held at the Institute of Child Health in London in 2002 with most of the study investigators (those from the Burkina Faso study did not attend), where agreement was reached on a common study protocol among those using the UNIMMAP supplement [3] . A further progress review meeting was held in Bangkok in 2004 [4] . Where studies had already begun prior to the meeting, investigators agreed to try to standardize data collection to increase comparability of data outputs. There was an agreement to share data on completion.
In October 2005, a Systematic Review Team was commissioned by UNICEF/WHO/United Nations System Standing Committee on Nutrition (SCN) to undertake a review of published studies and the analysis of the studies where principal investigators had previously agreed to share their data. In addition to the investigators who participated in the Bangkok meeting, others also agreed to share their data.
An advisory board was established, including program managers and policy makers who had been associated with multiple micronutrient programs [1] . Terms of reference were agreed upon (available on request). After a preliminary analysis of the studies, a review meeting was held with the advisory board, the principal investigators, and the Systematic Review Team presented summary reports of the published literature relating to the impact of multiple micronutrient supplementation during pregnancy on the mother's nutritional status, birth outcomes, and subsequent infant mortality. As a result of that meeting, participant principal investigators agreed to provide further information about their study designs so that as far as possible comparable information on each study population and background circumstances could be presented in the final report. Proposals for further analyses were made at this meeting, the results of which have been incorporated in the other papers presented in this supplement.
Methods

Studies included
The analyses reported in other papers in this issue are based on data from 12 studies. Nine of these (conducted in Bangladesh; Burkina Faso; China; Guinea-Bissau; Lombok, Indonesia; Indramayu, Indonesia; Janakpur, Nepal; Niger; and Pakistan) [5] [6] [7] [8] [9] [10] [11] [12] [13] used UNIM-MAP (see table 1), and the other three (conducted in Mexico [14] ; Sarlahi, Nepal [15] ; and Zimbabwe [16] ) used other multiple micronutrient supplements. The composition of the supplements used in these trials is summarized in table 1. All studies were randomized, controlled trials, with either individual or cluster randomization; some were factorial in design, where women were also randomized to additional interventions (behavior change, food, or treatments).
In most studies, the comparison (control) supplement was composed of 60 mg of iron and 400 µg of folic acid (iron-folic acid). The iron content of the UNIMMAP supplement was 30 mg. Women were given supplements either daily, weekly, fortnightly, or monthly, with compliance checked in a variety of ways. In Zimbabwe, women allocated to the control group were not given supplements but were encouraged to obtain standard antenatal care, which included ironfolic acid supplements.
Several studies had additional groups or different amounts of iron. In Bangladesh, there were two control supplements, one containing 60 mg of iron plus folic acid and the other 30 mg of iron pus folic acid. In the study in Sarlahi, Nepal, all women received vitamin A; the control group received only vitamin A while the other groups also received folic acid, folic acid plus iron, folic acid plus iron plus zinc, or a multiple micronutrient supplement. In the present analyses, we have compared the group receiving vitamin A, folic acid, and iron with the group receiving multiple micronutrients. In China, a third comparison group, which was not included in the meta-analyses, received folic acid only. In Lombok, Indonesia, the control supplement contained 30 mg of iron. In Guinea-Bissau, there were two intervention supplements: UNIMMAP and a supplement containing double the amount of the 
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Some studies used a factorial design to assess the impact of other simultaneous interventions (details are described further in table 3). For the purposes of the analyses reported here, we have assumed that there was no interaction between these other interventions and the effect of supplementation, since all interventions were randomized. In Burkina Faso [9] , there may have been an interaction between supplementation and antimalarial prophylaxis.
Meta-analysis
For each study, the raw data were reviewed and any queries were referred back to the principal investigators for clarification. Women who were known to be HIV-infected or who had multiple pregnancies were excluded from the analysis. In Burkina Faso and Mexico, some mothers (49 and 62 women, respectively) had more than one pregnancy during the study, and we included only the first birth in the analyses. For the mortality analyses, we also excluded women with fetal loss before 28 weeks and those for whom the outcome of the pregnancy was unknown. The analyses of birth outcomes were restricted to babies who were born alive after at least 28 weeks of gestation, who were measured within 72 hours after delivery, and whose gestational age at delivery was recorded as at least 28 weeks (196 days) and less than 45 weeks (315 days). Table 2 summarizes the characteristics of the trials for each study center. The number of mothers included ranged from 717 in Zimbabwe to 30,994 in Lombok, Indonesia. Data from a total of just over 52,000 women were collected and analyzed. In the birth outcome analyses, the numbers included in several trials were considerably smaller than the numbers in the total sample (and as tabulated in Table 2 ); for example, birth outcomes were analyzed for 13,270 of 30,994 women in Lombok, Indonesia, and 901 of 1,711 women in Pakistan. In some studies, it was difficult to perform measurements of birthweight within 3 days after delivery.
Results
Ten trials enrolled participants in the first trimester, and two enrolled them in both the second and the third trimesters. In Burkina Faso, 35% of women were recruited in the first trimester. Eight studies did not exclude women on the basis of gestational age at enrollment; four studies (China, Niger, Mexico, and Janakpur, Nepal) excluded women on the basis of gestational age. Women were excluded if gestational age at enrollment was greater than 28 weeks in China, 12 weeks in Niger, 13 weeks in Mexico, and 20 weeks in Janakpur, Nepal.
The average maternal age was similar across studies (range of means, 21.5 to 26.0 years). Parity differed considerably between studies; in China 62% of women were having their first child, as compared with 19% in Niger. The reported levels of maternal education also varied widely among studies. In some studies (Sarlahi, Nepal; Pakistan; Burkina Faso; and Niger) approximately 80% to 90% of women had received no formal education, whereas in China this proportion was much lower. The two studies from Nepal differed in the proportion of women with no education (45% in Janakpur and 81% in Sarlahi).
Maternal height and body mass index (BMI) varied considerably. Mean height ranged from 148.7 cm in Mexico to 162.2 cm in Burkina Faso, and mean BMI ranged from 19.3 kg/m 2 in Sarlahi, Nepal, to 25.0 kg/m 2 in Zimbabwe.
Six studies (the two studies in Indonesia and those in China; Sarlahi, Nepal; Pakistan; and Niger) were cluster randomized, whereas the other six were individually randomized trials. In Lombok, Indonesia, the unit of cluster randomization was the midwife; in all other cluster-randomized trials, the village was the unit of randomization. The design of the study was taken into account in the way studies were analyzed. Table 3 provides a description of the communities in each trial, with whatever information was available about other interventions or concurrent treatment protocols that may have been in place. In addition to supplements, the participants in most studies received some other form of intervention, allocated either in a factorial design or to the whole community. In Bangladesh, the supplement was given with a food supplement either early or late in pregnancy (as part of the Bangladesh Integrated Nutrition Programme [BINP]), and with or without metronidazole. In Indramayu, Indonesia, the women were given tablets on either a daily or a monthly basis to assess the impact on compliance. In Lombok, Indonesia, the whole community received a social marketing package, and each woman received a monthly visit from a community facilitator who provided health education. In Pakistan, women either received nutrition education or not, in addition to the supplement. In Sarlahi, Nepal, all women received antenatal care and nutrition advice at enrollment. In Janakpur, Nepal, anemic women and those described as night-blind received iron and vitamin A daily and were rechecked after 1 month. In Guinea-Bissau, severely anemic women were given additional iron, and all women received insecticide-impregnated bednets and weekly antimalarial prophylaxis. In Burkina Faso, in a factorial design, participants were also randomly assigned to receive either the malaria chemoprophylaxis recommended by health authorities (300 mg of chloroquine weekly ) or intermittent preventive treatment (1,500 mg of sulfadoxine and 75 mg of pyrimethamine once in either the second or the third trimester). Women were excluded if they were at 28 weeks or more of gestation at enrollment, were taking other supplements, or were seriously ill. Indonesia (Indramayu) [6] Two rural subdistricts covering 26 villages in Indramayu, West Java. Cluster randomized by 160 blocks within villages. Compliance: monthly pill count.
Groups were assigned to either daily ("efficacy") or monthly ("effectiveness") allocation of tablets.
Indonesia (Lombok) [8] All villages outside the capital city on the island of Lombok. Randomization based on 262 midwives serving the population. Compliance: women replenished their capsules each month from midwives who logged date and previous consumption by inspecting blister strips. Community facilitator also inspected blister strips during home visits.
Attended deliveries were supported by trained staff. Social marketing was provided to the whole community; women were visited monthly by community facilitators, who provided health education and promoted prenatal care and skilled care at delivery.
Nepal (Sarlahi) [15] Southeastern plains District of Sarlahi. Study area was 30 village development communities divided into 426 small units. Evidence of vitamin A, iron, and zinc deficiency in pregnant women. Compliance: sector workers delivered supplements twice weekly to women in their homes.
All women received counseling on antenatal care and nutrition at enrollment. They were encouraged to take iron supplements. Deworming (albendazole) medicine was offered in 2nd and 3rd trimesters. Women received tetanus toxoid vaccination twice during pregnancy, a safe birthing kit, and a flannel blanket for the newborn.
Nepal (Janakpur) [11] All women attending an antenatal clinic at Janakpur zonal hospital. Women were eligible if gestation ≤ 20 weeks; singleton pregnancy; no notable fetal abnormality; no existing maternal illness severe enough to compromise pregnancy outcome; and participant lived in Dhanusha or adjoining Mahottari, accessible for home visits. Compliance: contact visit every 2 weeks; compliance checked by a combination of monthly clinic visits and monthly home visits.
In the event of significant illness, the participant was seen by a consultant obstetrician or doctor. If a participant's enrollment hemoglobin concentration was less than 70 g/L, she was given an extra 60 mg of iron daily and anthelminthic treatment, and her hemoglobin was rechecked after 1 month; if a participant described night-blindness at any time, she was given 2,000 µg of vitamin A daily and referred for medical follow-up.
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Review of methods and characteristics of studies Pakistan [7] Urban population in Karachi and villages of Kot Diji District (rural Sindh). Allocated urban and rural areas to 28 discrete clusters (16 rural, 12 urban) based on household characteristics, socioeconomic criteria, and geographic location. Each cluster was allocated a community health worker who covered about 600 -700 households and 3,500-4,000 women. Compliance: community health workers provided 2-week supply of supplements (multiple micronutrients or iron-folic acid) and did a tablet count and stock replenishment at every 2-week visit.
Community outreach: in one group, the supplements were provided along with basic nutrition and antenatal care messages (focusing on the importance of maternal nutrition, antenatal care, and micronutrient supplements to avert maternal anemia) through home visits. In the other, the home visits were complemented with additional quarterly community-based group sessions held in the houses of community participants who volunteered.
Africa
Burkina Faso [9] Houndé health district (southwest of Burkina Faso) in area covered by 2 health centers. Only exclusion criterion was plan to leave area in next 2 years. Compliance: tablet intake was directly observed at daily home visits. Tablets were given in advance only for short scheduled absences. Home visitors updated reporting sheets daily, recording tablet intake, morbidity, and pregnancy complications.
Participants were also randomly assigned to receive either the malaria chemoprophylaxis recommended by health authorities (300 mg of chloroquine weekly) or intermittent preventive treatment (1,500 mg of sulfadoxine and 75 mg of pyrimethamine once in the 2nd and 3rd trimesters). In case of maternal illness, appropriate treatments were provided according to national guidelines. Severely anemic women (hemoglobin < 70 g/L, without dyspnea) received ferrous sulfate (200 mg) plus folic acid (0.25 mg) twice daily for 3 months, whatever their allocation group. All participants also received 400 mg of albendazole in the 2nd and 3rd trimesters. If malaria occurred in spite of chemoprophylaxis, quinine (300 mg, 3 times a day) was given for 5 days. Vitamin A (200,000 IU) was given to all women after delivery, in conformity with the national recommendations.
Guinea-Bissau [12] Semiurban area of Bissau: women were identified through monthly pregnancy surveillance in the Bandim Health Project and recruited until late pregnancy. Compliance: women were given containers with 25 tablets; tablets were counted every 2 weeks and replenished during home visits.
Women with severe anemia (hemoglobin < 70 g/L) were given an additional 60 mg of iron daily. All women received insecticide-impregnated bednets at inclusion and were provided weekly antimalarial prophylaxis with chloroquine phosphate throughout pregnancy. Those with > 10 parasites per 200 leukocytes at inclusion were offered chloroquine treatment.
Niger [13] Rural Niger in the north of the administrative region of Maradi. 78 villages within the coverage of the 17 health centers of Mayahi District were included. All of the villages -not individuals -were randomly assigned to the control or intervention group. Women were eligible to participate if they lived in a selected village and had amenorrhea for < 12 weeks. Compliance: 35 tablets were given monthly; compliance was measured by pill count. At each subsequent visit, the remaining pills were counted and the number of missing tablets was replenished for next month and recorded.
Women with night-blindness and/or clinical signs of severe anemia received appropriate medical treatment and were excluded from the study. Behavior change communication activities were conducted to increase awareness and encourage participation in the study and adoption of better lifestyles, including feeding practices and rest during pregnancy. Women received a free package of reproductive health services, including malaria chemoprophylaxis and appropriate case management.
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Compliance was measured in different ways. In Sarlahi, Nepal, women were contacted twice weekly by a sector distributor to monitor intake; in Janakpur, Nepal, and in Guinea-Bissau, the number of pills consumed was counted at each fortnightly visit; in Zimbabwe, there was a simple pill count after delivery. In Burkina Faso, tablet intake was directly observed in daily home visits. The average number of supplements reported as consumed was 165 in China; 164 in Mexico; 157 in Janakpur, Nepal; 152 in Sarlahi, Nepal; 124 in Lombok, Indonesia; 107 in Indramayu, Indonesia; 114 in Burkina Faso; 81 in Guinea-Bissau; and 62 in Zimbabwe.
Discussion
More than 52,000 women from 12 studies have been included in the meta-analyses; one study (Lombok, Indonesia) contributed over half of all the data, and two studies each contributed fewer than a thousand women. This variation in sample size needs to be considered when reviewing the findings from the meta-analysis.
The studies included in the meta-analyses were primarily from Asia and Africa, with only one from Latin America. The average birthweights differed by more than 500 g between the studies in Bangladesh and China and by about 150 g between the two studies in Nepal [17] . The average birthweights in the four African studies ranged from 2,900 to 3,050 g. There were large differences among studies in baseline nutritional status, with women in Bangladesh, Indonesia, Mexico, Nepal, and Pakistan being nearly 10 cm shorter than women in Africa and China. The mean BMI was highest in Guinea-Bissau, Mexico, and Zimbabwe and lowest in Nepal. There were also large differences in parity and levels of education among the women from different study centers. All these factors suggest differences in the 
Central and South America
Mexico [14] Near the city of Cuernavaca in Morelos.
All new pregnancies were identified by a routine home-based surveillance system in which fieldworkers visited women of reproductive age every 5 weeks. Women who agreed to participate were then randomly allocated to either the multiple micronutrient or the iron-only group. Exclusion criteria: > 13 weeks of pregnancy at recruitment, use of micronutrient supplements, refusal to participate. Compliance: the first supplement was consumed at the study headquarters, after which trained workers visited the women's homes 6 days per week until delivery to administer supplements and record their consumption.
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Review of methods and characteristics of studies living and public health circumstances of the women that may alter the impact of the supplementation on birth outcomes and mortality. It is also possible that both supplements improved outcome measures compared with the general populations from which the women were recruited. Most studies compared a multiple micronutrient supplement containing iron with an iron-folic acid supplement containing twice as much iron. One comparison group (Sarlahi, Nepal) received vitamin A as well as ironfolic acid. In the studies in Lombok, Indonesia, and in Bangladesh, the control group received 30 mg of iron, as compared with 60 mg in other studies.
The gestational age at which supplementation started, and thus the total exposure to supplementation, varied considerably across studies. Compliance was measured with different levels of accuracy. Further, the fact that four studies excluded women recruited after certain gestational dates and eight studies did not adds to the potential variation in study findings. There is a potential for interaction between the gestational age at which supplements commenced and the nutritional status of the mother at conception on the impact the supplementation had on outcomes. Studies were not a priori designed to assess this interaction, and although these factors have been included in analyses in subsequent papers, there is a strong possibility that these interactions have not been correctly disentangled.
Taken together, the differences in the wider environments in which women lived in each country, in baseline nutritional status, and in compliance (time of introduction and amount of supplement consumed) could all influence the way the supplements affected outcomes. This needs to be considered when interpreting the findings of the meta-analyses.
